Literature DB >> 12715012

Influence of the polymorphism of apolipoprotein E in cerebral vascular disease.

Dorotéia R S Souza1, Bernadete F Campos, Erika F de Arruda, Lucy J Yamamoto, Daniel M Trindade, Waldir A Tognola.   

Abstract

UNLABELLED: The genetic heterogeneity of apolipoprotein E (apo E) has been associated with lipid profile and atherothrombotic stroke, however this association remains inconclusive.
OBJECTIVE: To evaluate the relationship between the isoforms of apo E and atherothrombotic stroke, by ascertaining the frequency of its alleles and genotypes associated with the lipid profile in patients with stroke.
METHOD: A total of 207 individuals were divided into two groups, consisting of 107 patients with stroke and 100 individuals without clinical symptoms of the disease. Blood samples were taken from patients and controls for molecular investigation of the apo E (epsilon2, epsilon3 and epsilon4 alleles) for the analysis of the lipid profile.
RESULTS: The epsilon3 allele was the most common and its prevalence was significantly higher in patients (0.93) compared to the controls (0.86; p=0.024). The epsilon2 allele was rarely seen specifically in patients (0.02 versus 0.05 in controls, p=0.191). The epsilon4 allele was not associated with stroke showing a reduced frequency in patients (0.05) when compared to controls (0.09; p=0.011). Although higher average levels of lipid profile were found in patients when compared to controls, with statistical significance for the values of total cholesterol (TC) (203.6 mg/dL +/- 57.98 and 181.9 mg/dL +/- 68.47 respectively; p=0.003) and low-density lipoprotein cholesterol (LDLc) (131.4mg/dL +/- 52.60 and 116 mg/dL +/- 56.38, respectively; p=0.014), these were independent of the presence of the epsilon4 allele. In control group the higher TC and LDLc values occurred in the absence of the epsilon4 allele, confirming the conflicting effect of the alleles of apo E on the plasmatic lipids and atherothrombotic stroke.
CONCLUSION: The isoforms of apo E cannot be regarded as an isolated risk factor for stroke and do not show association with lipid profile in this study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12715012     DOI: 10.1590/s0004-282x2003000100002

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  5 in total

Review 1.  Association between Apolipoprotein ε4 Gene Polymorphism and Risk of Ischemic Stroke: A Meta-Analysis.

Authors:  Amit Kumar; Pradeep Kumar; Manya Prasad; Shubham Misra; Awadh Kishor Pandit; Kamalesh Chakravarty
Journal:  Ann Neurosci       Date:  2016-07-07

2.  Apolipoprotein E genetic polymorphism, serum lipoprotein levels and breast cancer risk: A case-control study.

Authors:  Gabriela Herrmann Cibeira; Juliana Giacomazzi; Ernestina Aguiar; Silvana Schneider; Betina Ettrich; Caroline Isoppo DE Souza; Suzi Camey; Maira Caleffi; Bernardete Weber; Patricia Ashton-Prolla; Emilio Hideyuki Moriguchi
Journal:  Mol Clin Oncol       Date:  2014-08-01

3.  Apolipoprotein e, alcohol consumption, and risk of ischemic stroke: the Framingham Heart Study revisited.

Authors:  Luc Djoussé; Jayandra J Himali; Alexa Beiser; Margaret Kelly-Hayes; Philip A Wolf
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Sep-Oct       Impact factor: 2.136

Review 4.  Genetics of atherothrombotic and lacunar stroke.

Authors:  Stéphanie Debette; Sudha Seshadri
Journal:  Circ Cardiovasc Genet       Date:  2009-04

5.  Apolipoprotein E ε4 Polymorphism as a Risk Factor for Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Su-Ya Qiao; Ke Shang; Yun-Hui Chu; Hai-Han Yu; Xin Chen; Chuan Qin; Deng-Ji Pan; Dai-Shi Tian
Journal:  Dis Markers       Date:  2022-02-03       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.